Breaking News Instant updates and real-time market news.

IONS

Ionis Pharmaceuticals

$30.10

-0.55 (-1.79%)

12:15
10/14/16
10/14
12:15
10/14/16
12:15

Ionis Pharmaceuticals put volume heavy and directionally bearish

Bearish flow noted in Ionis Pharmaceuticals with 1,900 puts trading, or 7x expected. Most active are Oct-16 31 puts and Oct-16 25 puts, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 3.17, while ATM IV is up over 5 points on the day. Earnings are expected on November 9th.

  • 29

    Nov

  • 14

    Dec

IONS Ionis Pharmaceuticals
$30.10

-0.55 (-1.79%)

10/06/16
RBCM
10/06/16
NO CHANGE
RBCM
Alnylam news not a negative read through on other RNAi drugs, says RBC Capital
After Alnylam (ALNY) announced that it was discontinuing one of its Phase III RNAi drugs due to poor clinical outcomes, RBC Capital analyst Michael Yee does not thinks that the news indicates problems with all RNAi drugs. Rather, he thinks that RNAi was not the proper treatment for the disease that Alnylam was targeting. Other companies with RNAi treatments include The Medicines Company (MDCO0, Ionis Pharmaceuticals (IONS), Arrowhead (ARWR), and Arbutus Biopharma (ABUS).
10/06/16
WELS
10/06/16
NO CHANGE
WELS
Ionis has no read through from negative Alnylam data, says Wells Fargo
After Ionis (IONS) competitor Alnylam Pharmaceuticals (ALNY) announced that it was terminating the development of its revusiran RNAi drug due to poor outcomes in clinical trials, Wells Fargo thinks that the news is "a significant positive" for Ionis because it eliminates a competitor. The firm says that Ionis' drug is significantly different than Alnylam's product, and it believes that Ionis' treatment appears to be superior. The firm keeps an Outperform rating on Ionis.
10/06/16
BMOC
10/06/16
UPGRADE
BMOC
Outperform
Ionis Pharmaceuticals upgraded on reduced competition, valuation at BMO Capital
As noted earlier, BMO Capital upgraded Ionis (IONS) to Outperform from Market Perform. After Alnylam (ALNY) announced that it was discontinuing one of its Phase III RNAi drugs due to poor clinical outcomes, BMO Capital analyst Do Kim expects Ionis to benefit from the reduced competition. Kim recommends buying Ionis' stock on weakness today. Target to $48 from $42.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Ionis drug likely to be approved rapidly, says Wells Fargo
After Ionis Pharmaceuticals (IONS) and partner Biogen (BIIB) reported detailed data for their RNA Therapeutic nusinersen, in patients with both symptomatic and pre-symptomatic type 1 Spinal Muscular Atrophy, as well as data for patients with type 2/3 Spinal Muscular Atrophy, or SMA, Wells Fargo says it expects the drug to be rapidly approved. The firm thinks that the FDA will approve "a broad label" covering pre-symptomatic and symptomatic type I SMA, as well as type 2/3 SMA. The firm says that the companies should have "a very large commercial opportunity," and it keeps an Outperform rating on Ionis.

TODAY'S FREE FLY STORIES

CXP

Columbia Property

$23.01

0.04 (0.17%)

05:40
02/22/17
02/22
05:40
02/22/17
05:40
Upgrade
Columbia Property rating change  »

Columbia Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

DISCA

Discovery

$29.62

0.94 (3.28%)

05:38
02/22/17
02/22
05:38
02/22/17
05:38
Downgrade
Discovery rating change  »

Discovery downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISIL

Intersil

$22.20

0.02 (0.09%)

, RNECY

Renesas

05:38
02/22/17
02/22
05:38
02/22/17
05:38
Hot Stocks
Intersil, Renesas announce regulatory approval for acquisition of Intersil »

Renesas Electronics…

ISIL

Intersil

$22.20

0.02 (0.09%)

RNECY

Renesas

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTL

Entellus Medical

$17.08

0.06 (0.35%)

05:36
02/22/17
02/22
05:36
02/22/17
05:36
Downgrade
Entellus Medical rating change  »

Entellus Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$16.05

-2.95 (-15.53%)

05:34
02/22/17
02/22
05:34
02/22/17
05:34
Downgrade
Momenta rating change  »

Leerink downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$78.44

0.66 (0.85%)

05:33
02/22/17
02/22
05:33
02/22/17
05:33
Hot Stocks
Bunge forms JV with Bahri, terms not disclosed »

Bahri Dry Bulk, or BDB, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AU

AngloGold

$12.54

-0.36 (-2.79%)

05:30
02/22/17
02/22
05:30
02/22/17
05:30
Downgrade
AngloGold rating change  »

AngloGold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$31.99

0.5 (1.59%)

05:27
02/22/17
02/22
05:27
02/22/17
05:27
Hot Stocks
Toll Brothers backs FY17 adjusted gross margin »

Toll Brothers reaffirms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

STM

STMicroelectronics

$14.64

0.38 (2.66%)

05:27
02/22/17
02/22
05:27
02/22/17
05:27
Upgrade
STMicroelectronics rating change  »

STMicroelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZSEY

Allianz

$17.45

0.13 (0.75%)

05:25
02/22/17
02/22
05:25
02/22/17
05:25
Initiation
Allianz initiated  »

Allianz initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IHG

InterContinental

$48.62

0.42 (0.87%)

05:25
02/22/17
02/22
05:25
02/22/17
05:25
Downgrade
InterContinental rating change  »

InterContinental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUKOY

Lukoil

$55.80

0.87 (1.58%)

05:24
02/22/17
02/22
05:24
02/22/17
05:24
Upgrade
Lukoil rating change  »

Lukoil upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$31.99

0.5 (1.59%)

05:23
02/22/17
02/22
05:23
02/22/17
05:23
Earnings
Toll Brothers reports Q1 EPS 42c, consensus 35c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

QCOM

Qualcomm

$56.75

0.29 (0.51%)

, CHL

China Mobile

$56.46

0.35 (0.62%)

05:17
02/22/17
02/22
05:17
02/22/17
05:17
Hot Stocks
Qualcomm, China Mobile, ZTE announce collaboration on 5G NR trials »

Qualcomm Technologies, a…

QCOM

Qualcomm

$56.75

0.29 (0.51%)

CHL

China Mobile

$56.46

0.35 (0.62%)

ZTCOY

ZTE Corp.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

ECL

Ecolab

$124.03

0.08 (0.06%)

04:58
02/22/17
02/22
04:58
02/22/17
04:58
Downgrade
Ecolab rating change  »

Ecolab downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$61.02

1.79 (3.02%)

, TSN

Tyson Foods

$63.31

-1.95 (-2.99%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
The Consumer Analyst Group of New York to hold a conference »

2017 CAGNY Conference is…

GIS

General Mills

$61.02

1.79 (3.02%)

TSN

Tyson Foods

$63.31

-1.95 (-2.99%)

TWNK

Hostess Brands

$15.47

-0.13 (-0.83%)

MJN

Mead Johnson

$87.47

-0.03 (-0.03%)

K

Kellogg

$74.74

1.84 (2.52%)

MDLZ

Mondelez

$44.97

2.47 (5.81%)

INGR

Ingredion

$122.02

1.23 (1.02%)

LNCE

Snyder's-Lance

$39.38

0.38 (0.97%)

SYY

Sysco

$52.81

0.46 (0.88%)

JNJ

Johnson & Johnson

$119.66

0.8 (0.67%)

SJM

J.M. Smucker

$141.92

5.97 (4.39%)

MO

Altria Group

$73.65

0.68 (0.93%)

CPB

Campbell Soup

$58.95

0.47 (0.80%)

PEP

PepsiCo

$109.36

1.21 (1.12%)

CLX

Clorox

$135.44

1.73 (1.29%)

BG

Bunge

$78.44

0.66 (0.85%)

PG

Procter & Gamble

$91.67

0.58 (0.64%)

DANOY

Danone

$12.92

-0.125 (-0.96%)

SPB

Spectrum Brands

$134.58

0.67 (0.50%)

KO

Coca-Cola

$41.46

0.23 (0.56%)

IFF

International Flavors

$121.62

-0.75 (-0.61%)

STZ

Constellation Brands

$160.09

-1.23 (-0.76%)

NSRGY

Nestle

$72.92

-0.825 (-1.12%)

CHD

Church & Dwight

$49.61

-0.09 (-0.18%)

UN

Unilever; also tag UL

$45.09

-3.7 (-7.58%)

CL

Colgate-Palmolive

$73.18

1.2 (1.67%)

NWL

Newell Brands

$46.49

-0.15 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 24

    Feb

  • 09

    Mar

  • 14

    Mar

  • 15

    Mar

  • 19

    Mar

  • 27

    Mar

  • 09

    May

RIO

Rio Tinto

$44.89

0.65 (1.47%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Rio Tinto management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 24

    Feb

  • 26

    Feb

CRUS

Cirrus Logic

$55.17

-0.16 (-0.29%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Cirrus Logic management to meet with Canaccord »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

VWDRY

Vestas

$24.97

0.34 (1.38%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Vestas management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

MPWR

Monolithic Power

$88.22

1.7 (1.96%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Monolithic Power management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 04

    Apr

  • 05

    Apr

WEB

Web.com

$20.40

0.2 (0.99%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Web.com management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

OCLR

Oclaro

$10.97

-0.05 (-0.45%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Oclaro management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

HAS

Hasbro

$98.88

0.38 (0.39%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Hasbro management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

FLWS

1-800-Flowers.com

$10.10

0.1 (1.00%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
1-800-Flowers.com management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

04:55
02/22/17
02/22
04:55
02/22/17
04:55
General news
Breaking General news story  »

FOMC Minutes to be…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.